{
  "query":
  {
    "id": null,
    "referenceGenome": "GRCh37",
    "hugoSymbol": "TP53",
    "entrezGeneId": 7157,
    "alteration": "Deletion",
    "alterationType": "MUTATION",
    "svType": null,
    "tumorType": null,
    "consequence": "NA",
    "proteinStart": -1,
    "proteinEnd": 100000,
    "hgvs": null
  },
  "geneExist": true,
  "variantExist": true,
  "alleleExist": false,
  "oncogenic": "Likely Oncogenic",
  "mutationEffect":
  {
    "knownEffect": "Likely Loss-of-function",
    "description": "TP53 deletions are predicted to be inactivating and associated with poor prognosis (PMID: 11900253, 20697090, 21467160, 12584563). Experimental studies have revealed that deletions result in loss of TP53 tumor suppressive function, since TP53 cannot decrease cell viability in vitro (PMID: 27759562). Additionally, deletion of TP53 in the neurons of mice, while not sufficient to cause tumor development, allows the accumulation of other oncogenic mutations leading to tumorigenesis (PMID: 19477430). Further, loss of TP53 protein during 17p deletion events in leukemia/lymphoma, enhances cancer development through cooperation of linked tumor suppressive genes such as EIF5A and ALOX15B (PMID: 26982726).",
    "citations":
    {
      "pmids":
      [
        "26982726",
        "20697090",
        "27759562",
        "19477430",
        "11900253",
        "12584563",
        "21467160"
      ],
      "abstracts":
      []
    }
  },
  "highestSensitiveLevel": null,
  "highestResistanceLevel": null,
  "highestDiagnosticImplicationLevel": null,
  "highestPrognosticImplicationLevel": "LEVEL_Px1",
  "highestFdaLevel": null,
  "otherSignificantSensitiveLevels":
  [],
  "otherSignificantResistanceLevels":
  [],
  "hotspot": false,
  "geneSummary": "TP53, a tumor suppressor in the DNA damage pathway, is the most frequently mutated gene in cancer.",
  "variantSummary": "TP53 deletion is likely oncogenic.",
  "tumorTypeSummary": "",
  "prognosticSummary": "",
  "diagnosticSummary": "",
  "diagnosticImplications":
  [],
  "prognosticImplications":
  [
    {
      "levelOfEvidence": "LEVEL_Px1",
      "alterations":
      [
        "Deletion"
      ],
      "tumorType":
      {
        "id": 645,
        "code": "PCM",
        "color": "LimeGreen",
        "name": "Plasma Cell Myeloma",
        "mainType":
        {
          "id": null,
          "name": "Mature B-Cell Neoplasms",
          "tumorForm": "LIQUID"
        },
        "tissue": "Lymphoid",
        "children":
        {},
        "parent": "MBN",
        "level": 5,
        "tumorForm": "LIQUID"
      },
      "pmids":
      [
        "17209057",
        "9680348",
        "18337559"
      ],
      "abstracts":
      [
        {
          "link": "http://www.bloodjournal.org/content/128/22/3271?sso-checked=true",
          "abstract": "Hofste op Bruinink, D. et al. Abstract# Blood 128:3271, 2017"
        }
      ],
      "description": "This assertion is supported by (PMID: 9680348, 18337559, 17209057 Abstract: Hofste op Bruinink, D. et al. Abstract# Blood 128:3271, 2017. http://www.bloodjournal.org/content/128/22/3271?sso-checked=true; http://www.bloodjournal.org/content/122/21/1846)."
    },
    {
      "levelOfEvidence": "LEVEL_Px1",
      "alterations":
      [
        "Oncogenic Mutations"
      ],
      "tumorType":
      {
        "id": 17,
        "code": "AMLMRC",
        "color": "LightSalmon",
        "name": "AML with Myelodysplasia-Related Changes",
        "mainType":
        {
          "id": null,
          "name": "Leukemia",
          "tumorForm": "LIQUID"
        },
        "tissue": "Myeloid",
        "children":
        {},
        "parent": "AML",
        "level": 4,
        "tumorForm": "LIQUID"
      },
      "pmids":
      [
        "25412851",
        "25860933"
      ],
      "abstracts":
      [],
      "description": "This assertion is supported by (PMID: 25860933, 25412851)."
    },
    {
      "levelOfEvidence": "LEVEL_Px1",
      "alterations":
      [
        "Oncogenic Mutations"
      ],
      "tumorType":
      {
        "id": 527,
        "code": "AML",
        "color": "LightSalmon",
        "name": "Acute Myeloid Leukemia",
        "mainType":
        {
          "id": null,
          "name": "Leukemia",
          "tumorForm": "LIQUID"
        },
        "tissue": "Myeloid",
        "children":
        {},
        "parent": "MNM",
        "level": 3,
        "tumorForm": "LIQUID"
      },
      "pmids":
      [
        "22186996",
        "18596741"
      ],
      "abstracts":
      [],
      "description": "This assertion is supported by (PMID: 22186996, 18596741)."
    },
    {
      "levelOfEvidence": "LEVEL_Px1",
      "alterations":
      [
        "Oncogenic Mutations"
      ],
      "tumorType":
      {
        "id": 418,
        "code": "TMN",
        "color": "LightSalmon",
        "name": "Therapy-Related Myeloid Neoplasms",
        "mainType":
        {
          "id": null,
          "name": "Leukemia",
          "tumorForm": "LIQUID"
        },
        "tissue": "Myeloid",
        "children":
        {},
        "parent": "AML",
        "level": 4,
        "tumorForm": "LIQUID"
      },
      "pmids":
      [
        "25412846",
        "25952993"
      ],
      "abstracts":
      [],
      "description": "This assertion is supported by (PMID: 25412846, 25952993)."
    },
    {
      "levelOfEvidence": "LEVEL_Px1",
      "alterations":
      [
        "Oncogenic Mutations"
      ],
      "tumorType":
      {
        "id": 533,
        "code": "CLLSLL",
        "color": "LimeGreen",
        "name": "Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma",
        "mainType":
        {
          "id": null,
          "name": "Mature B-Cell Neoplasms",
          "tumorForm": "LIQUID"
        },
        "tissue": "Lymphoid",
        "children":
        {},
        "parent": "MBN",
        "level": 5,
        "tumorForm": "LIQUID"
      },
      "pmids":
      [
        "23243274",
        "24004666",
        "20697090",
        "19188171",
        "24652989"
      ],
      "abstracts":
      [],
      "description": "This assertion is supported by (PMID: 19188171, 20697090, 24652989, 23243274, 24004666)."
    },
    {
      "levelOfEvidence": "LEVEL_Px1",
      "alterations":
      [
        "Oncogenic Mutations"
      ],
      "tumorType":
      {
        "id": 355,
        "code": "MDS",
        "color": "LightSalmon",
        "name": "Myelodysplastic Syndromes",
        "mainType":
        {
          "id": null,
          "name": "Myelodysplastic Syndromes",
          "tumorForm": "LIQUID"
        },
        "tissue": "Myeloid",
        "children":
        {},
        "parent": "MNM",
        "level": 3,
        "tumorForm": "LIQUID"
      },
      "pmids":
      [
        "21714648",
        "25092778",
        "24220272"
      ],
      "abstracts":
      [],
      "description": "This assertion is supported by (PMID: 24220272, 21714648, 25092778)."
    },
    {
      "levelOfEvidence": "LEVEL_Px1",
      "alterations":
      [
        "Oncogenic Mutations"
      ],
      "tumorType":
      {
        "id": 695,
        "code": "ET",
        "color": "LightSalmon",
        "name": "Essential Thrombocythemia",
        "mainType":
        {
          "id": null,
          "name": "Myeloproliferative Neoplasms",
          "tumorForm": "LIQUID"
        },
        "tissue": "Myeloid",
        "children":
        {},
        "parent": "MPN",
        "level": 4,
        "tumorForm": "LIQUID"
      },
      "pmids":
      [
        "24478400",
        "29296692",
        "22887079"
      ],
      "abstracts":
      [],
      "description": "This assertion is supported by (PMID: 22887079, 29296692, 24478400)."
    },
    {
      "levelOfEvidence": "LEVEL_Px1",
      "alterations":
      [
        "Oncogenic Mutations"
      ],
      "tumorType":
      {
        "id": 185,
        "code": "MPN",
        "color": "LightSalmon",
        "name": "Myeloproliferative Neoplasms",
        "mainType":
        {
          "id": null,
          "name": "Myeloproliferative Neoplasms",
          "tumorForm": "LIQUID"
        },
        "tissue": "Myeloid",
        "children":
        {},
        "parent": "MNM",
        "level": 3,
        "tumorForm": "LIQUID"
      },
      "pmids":
      [
        "25516983",
        "22052707",
        "22887079"
      ],
      "abstracts":
      [],
      "description": "This assertion is supported by (PMID: 22887079, 25516983, 22052707)."
    },
    {
      "levelOfEvidence": "LEVEL_Px1",
      "alterations":
      [
        "Oncogenic Mutations"
      ],
      "tumorType":
      {
        "id": 632,
        "code": "PMF",
        "color": "LightSalmon",
        "name": "Primary Myelofibrosis",
        "mainType":
        {
          "id": null,
          "name": "Myeloproliferative Neoplasms",
          "tumorForm": "LIQUID"
        },
        "tissue": "Myeloid",
        "children":
        {},
        "parent": "MPN",
        "level": 4,
        "tumorForm": "LIQUID"
      },
      "pmids":
      [
        "25516983",
        "22052707",
        "22887079"
      ],
      "abstracts":
      [],
      "description": "This assertion is supported by (PMID: 22887079, 25516983, 22052707)."
    },
    {
      "levelOfEvidence": "LEVEL_Px3",
      "alterations":
      [
        "Oncogenic Mutations"
      ],
      "tumorType":
      {
        "id": 586,
        "code": "MCL",
        "color": "LimeGreen",
        "name": "Mantle Cell Lymphoma",
        "mainType":
        {
          "id": null,
          "name": "Mature B-Cell Neoplasms",
          "tumorForm": "LIQUID"
        },
        "tissue": "Lymphoid",
        "children":
        {},
        "parent": "MBN",
        "level": 5,
        "tumorForm": "LIQUID"
      },
      "pmids":
      [
        "8639789",
        "7579380",
        "28819011",
        "24684350",
        "26022239"
      ],
      "abstracts":
      [],
      "description": "This assertion is supported by (PMID: 28819011, 26022239, 24684350, 8639789, 7579380)."
    }
  ],
  "treatments":
  [],
  "dataVersion": "V4.3",
  "lastUpdate": "07/18/2019",
  "background": "TP53 encodes the p53 tumor suppressor protein, a transcription factor that responds to cellular stresses, including DNA damage and oncogenic activation, by inducing downstream anti-tumor responses such as DNA repair and apoptosis (PMID: 11099028). TP53 is the most commonly mutated gene in human cancers, and germline mutations occur in the cancer predisposition syndrome Li-Fraumeni (PMID: 22713868, 21765642). The p53 protein consists of an N-terminal transactivation domain, a central DNA-binding domain, an oligomerization domain and a C-terminal regulatory domain (PMID: 22713868).",
  "tumorTypes":
  [
    {
      "relevantTumorType": false,
      "tumorType":
      {
        "id": 17,
        "subtype": "AML with Myelodysplasia-Related Changes",
        "code": "AMLMRC",
        "color": "LightSalmon",
        "mainType": "Leukemia",
        "level": 4,
        "tissue": "Myeloid",
        "tumorForm": "LIQUID"
      },
      "evidences":
      [
        {
          "id": 25654,
          "uuid": "ee6b8c2d-0e7a-42bb-ab8f-ef29344cd081",
          "evidenceType": "PROGNOSTIC_IMPLICATION",
          "cancerTypes":
          [
            {
              "id": 17,
              "subtype": "AML with Myelodysplasia-Related Changes",
              "code": "AMLMRC",
              "color": "LightSalmon",
              "mainType": "Leukemia",
              "level": 4,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            }
          ],
          "excludedCancerTypes":
          [],
          "relevantCancerTypes":
          [
            {
              "id": 17,
              "subtype": "AML with Myelodysplasia-Related Changes",
              "code": "AMLMRC",
              "color": "LightSalmon",
              "mainType": "Leukemia",
              "level": 4,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            }
          ],
          "gene":
          {
            "entrezGeneId": 7157,
            "hugoSymbol": "TP53",
            "oncogene": false,
            "grch37Isoform": "ENST00000269305",
            "grch37RefSeq": "NM_000546.5",
            "grch38Isoform": "ENST00000269305",
            "grch38RefSeq": "NM_000546.5",
            "geneAliases":
            [
              "LFS1",
              "p53"
            ],
            "genesets":
            [],
            "tsg": true
          },
          "alterations":
          [
            {
              "gene":
              {
                "entrezGeneId": 7157,
                "hugoSymbol": "TP53",
                "oncogene": false,
                "grch37Isoform": "ENST00000269305",
                "grch37RefSeq": "NM_000546.5",
                "grch38Isoform": "ENST00000269305",
                "grch38RefSeq": "NM_000546.5",
                "geneAliases":
                [
                  "LFS1",
                  "p53"
                ],
                "genesets":
                [],
                "tsg": true
              },
              "consequence":
              {
                "term": "NA",
                "isGenerallyTruncating": false,
                "description": "NA"
              },
              "alteration": "Oncogenic Mutations",
              "name": "Oncogenic Mutations",
              "refResidues": null,
              "proteinStart": -1,
              "proteinEnd": 100000,
              "variantResidues": null,
              "referenceGenomes":
              [
                "GRCh38",
                "GRCh37"
              ]
            }
          ],
          "description": "This assertion is supported by (PMID: 25860933, 25412851).",
          "additionalInfo": null,
          "treatments":
          [],
          "knownEffect": null,
          "lastEdit": 1600293135000,
          "lastReview": null,
          "levelOfEvidence": "LEVEL_Px1",
          "fdaLevel": null,
          "solidPropagationLevel": null,
          "liquidPropagationLevel": null,
          "articles":
          [
            {
              "pmid": "25860933",
              "title": "Role of ASXL1 and TP53 mutations in the molecular classification and prognosis of acute myeloid leukemias with myelodysplasia-related changes.",
              "journal": "Oncotarget",
              "pubDate": "2015 Apr 10",
              "volume": "6",
              "issue": "10",
              "pages": "8388-96",
              "authors": "Devillier R et al",
              "elocationId": "",
              "link": null,
              "reference": "Devillier R et al. Oncotarget. 2015 Apr 10;6(10)8388-96.",
              "abstract": null
            },
            {
              "pmid": "25412851",
              "title": "Next-generation sequencing of acute myeloid leukemia identifies the significance of TP53, U2AF1, ASXL1, and TET2 mutations.",
              "journal": "Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc",
              "pubDate": "2015 May",
              "volume": "28",
              "issue": "5",
              "pages": "706-14",
              "authors": "Ohgami RS et al",
              "elocationId": "doi: 10.1038/modpathol.2014.160",
              "link": null,
              "reference": "Ohgami RS et al. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2015 May;28(5)706-14.",
              "abstract": null
            }
          ]
        }
      ]
    },
    {
      "relevantTumorType": false,
      "tumorType":
      {
        "id": 418,
        "subtype": "Therapy-Related Myeloid Neoplasms",
        "code": "TMN",
        "color": "LightSalmon",
        "mainType": "Leukemia",
        "level": 4,
        "tissue": "Myeloid",
        "tumorForm": "LIQUID"
      },
      "evidences":
      [
        {
          "id": 25658,
          "uuid": "17eadd11-3a15-408a-853b-121286199008",
          "evidenceType": "PROGNOSTIC_IMPLICATION",
          "cancerTypes":
          [
            {
              "id": 418,
              "subtype": "Therapy-Related Myeloid Neoplasms",
              "code": "TMN",
              "color": "LightSalmon",
              "mainType": "Leukemia",
              "level": 4,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            }
          ],
          "excludedCancerTypes":
          [],
          "relevantCancerTypes":
          [
            {
              "id": 418,
              "subtype": "Therapy-Related Myeloid Neoplasms",
              "code": "TMN",
              "color": "LightSalmon",
              "mainType": "Leukemia",
              "level": 4,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 468,
              "subtype": "Therapy-Related Acute Myeloid Leukemia",
              "code": "TAML",
              "color": "LightSalmon",
              "mainType": "Leukemia",
              "level": 5,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 6,
              "subtype": "Therapy-Related Myelodysplastic Syndrome",
              "code": "TMDS",
              "color": "LightSalmon",
              "mainType": "Leukemia",
              "level": 5,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            }
          ],
          "gene":
          {
            "entrezGeneId": 7157,
            "hugoSymbol": "TP53",
            "oncogene": false,
            "grch37Isoform": "ENST00000269305",
            "grch37RefSeq": "NM_000546.5",
            "grch38Isoform": "ENST00000269305",
            "grch38RefSeq": "NM_000546.5",
            "geneAliases":
            [
              "LFS1",
              "p53"
            ],
            "genesets":
            [],
            "tsg": true
          },
          "alterations":
          [
            {
              "gene":
              {
                "entrezGeneId": 7157,
                "hugoSymbol": "TP53",
                "oncogene": false,
                "grch37Isoform": "ENST00000269305",
                "grch37RefSeq": "NM_000546.5",
                "grch38Isoform": "ENST00000269305",
                "grch38RefSeq": "NM_000546.5",
                "geneAliases":
                [
                  "LFS1",
                  "p53"
                ],
                "genesets":
                [],
                "tsg": true
              },
              "consequence":
              {
                "term": "NA",
                "isGenerallyTruncating": false,
                "description": "NA"
              },
              "alteration": "Oncogenic Mutations",
              "name": "Oncogenic Mutations",
              "refResidues": null,
              "proteinStart": -1,
              "proteinEnd": 100000,
              "variantResidues": null,
              "referenceGenomes":
              [
                "GRCh38",
                "GRCh37"
              ]
            }
          ],
          "description": "This assertion is supported by (PMID: 25412846, 25952993).",
          "additionalInfo": null,
          "treatments":
          [],
          "knownEffect": null,
          "lastEdit": 1600293135000,
          "lastReview": null,
          "levelOfEvidence": "LEVEL_Px1",
          "fdaLevel": null,
          "solidPropagationLevel": null,
          "liquidPropagationLevel": null,
          "articles":
          [
            {
              "pmid": "25412846",
              "title": "High p53 protein expression in therapy-related myeloid neoplasms is associated with adverse karyotype and poor outcome.",
              "journal": "Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc",
              "pubDate": "2015 Apr",
              "volume": "28",
              "issue": "4",
              "pages": "552-63",
              "authors": "Cleven AH et al",
              "elocationId": "doi: 10.1038/modpathol.2014.153",
              "link": null,
              "reference": "Cleven AH et al. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2015 Apr;28(4)552-63.",
              "abstract": null
            },
            {
              "pmid": "25952993",
              "title": "TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseases.",
              "journal": "Journal of hematology & oncology",
              "pubDate": "2015 May 8",
              "volume": "8",
              "issue": "",
              "pages": "45",
              "authors": "Ok CY et al",
              "elocationId": "doi: 10.1186/s13045-015-0139-z",
              "link": null,
              "reference": "Ok CY et al. Journal of hematology & oncology. 2015 May 8;8()45.",
              "abstract": null
            }
          ]
        }
      ]
    },
    {
      "relevantTumorType": false,
      "tumorType":
      {
        "id": 355,
        "subtype": "Myelodysplastic Syndromes",
        "code": "MDS",
        "color": "LightSalmon",
        "mainType": "Myelodysplastic Syndromes",
        "level": 3,
        "tissue": "Myeloid",
        "tumorForm": "LIQUID"
      },
      "evidences":
      [
        {
          "id": 25662,
          "uuid": "4e8b3dca-b8a1-43bf-986a-54d18b445ceb",
          "evidenceType": "PROGNOSTIC_IMPLICATION",
          "cancerTypes":
          [
            {
              "id": 355,
              "subtype": "Myelodysplastic Syndromes",
              "code": "MDS",
              "color": "LightSalmon",
              "mainType": "Myelodysplastic Syndromes",
              "level": 3,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            }
          ],
          "excludedCancerTypes":
          [],
          "relevantCancerTypes":
          [
            {
              "id": 337,
              "subtype": "MDS with Ring Sideroblasts and Single Lineage Dysplasia",
              "code": "MDSRSSLD",
              "color": "LightSalmon",
              "mainType": "Myelodysplastic Syndromes",
              "level": 5,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 770,
              "subtype": "MDS with excess blasts-1",
              "code": "MDSEB1",
              "color": "LightSalmon",
              "mainType": "Myelodysplastic Syndromes",
              "level": 5,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 355,
              "subtype": "Myelodysplastic Syndromes",
              "code": "MDS",
              "color": "LightSalmon",
              "mainType": "Myelodysplastic Syndromes",
              "level": 3,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 99,
              "subtype": "MDS with Isolated Del(5q)",
              "code": "MDSID5Q",
              "color": "LightSalmon",
              "mainType": "Myelodysplastic Syndromes",
              "level": 4,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 227,
              "subtype": "MDS with Multilineage Dysplasia",
              "code": "MDSMD",
              "color": "LightSalmon",
              "mainType": "Myelodysplastic Syndromes",
              "level": 4,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 709,
              "subtype": "MDS, Unclassifiable",
              "code": "MDSU",
              "color": "LightSalmon",
              "mainType": "Myelodysplastic Syndromes",
              "level": 4,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 680,
              "subtype": "Refractory Cytopenia of Childhood",
              "code": "RCYC",
              "color": "LightSalmon",
              "mainType": "Myelodysplastic Syndromes",
              "level": 4,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 840,
              "subtype": "MDS with Ring Sideroblasts and Multilineage Dysplasia",
              "code": "MDSRSMD",
              "color": "LightSalmon",
              "mainType": "Myelodysplastic Syndromes",
              "level": 5,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 362,
              "subtype": "MDS with Excess Blasts",
              "code": "MDSEB",
              "color": "LightSalmon",
              "mainType": "Myelodysplastic Syndromes",
              "level": 4,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 378,
              "subtype": "MDS with excess blasts-2",
              "code": "MDSEB2",
              "color": "LightSalmon",
              "mainType": "Myelodysplastic Syndromes",
              "level": 5,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 267,
              "subtype": "MDS with Ring Sideroblasts",
              "code": "MDSRS",
              "color": "LightSalmon",
              "mainType": "Myelodysplastic Syndromes",
              "level": 4,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 606,
              "subtype": "MDS with Single Lineage Dysplasia",
              "code": "MDSSLD",
              "color": "LightSalmon",
              "mainType": "Myelodysplastic Syndromes",
              "level": 4,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            }
          ],
          "gene":
          {
            "entrezGeneId": 7157,
            "hugoSymbol": "TP53",
            "oncogene": false,
            "grch37Isoform": "ENST00000269305",
            "grch37RefSeq": "NM_000546.5",
            "grch38Isoform": "ENST00000269305",
            "grch38RefSeq": "NM_000546.5",
            "geneAliases":
            [
              "LFS1",
              "p53"
            ],
            "genesets":
            [],
            "tsg": true
          },
          "alterations":
          [
            {
              "gene":
              {
                "entrezGeneId": 7157,
                "hugoSymbol": "TP53",
                "oncogene": false,
                "grch37Isoform": "ENST00000269305",
                "grch37RefSeq": "NM_000546.5",
                "grch38Isoform": "ENST00000269305",
                "grch38RefSeq": "NM_000546.5",
                "geneAliases":
                [
                  "LFS1",
                  "p53"
                ],
                "genesets":
                [],
                "tsg": true
              },
              "consequence":
              {
                "term": "NA",
                "isGenerallyTruncating": false,
                "description": "NA"
              },
              "alteration": "Oncogenic Mutations",
              "name": "Oncogenic Mutations",
              "refResidues": null,
              "proteinStart": -1,
              "proteinEnd": 100000,
              "variantResidues": null,
              "referenceGenomes":
              [
                "GRCh38",
                "GRCh37"
              ]
            }
          ],
          "description": "This assertion is supported by (PMID: 24220272, 21714648, 25092778).",
          "additionalInfo": null,
          "treatments":
          [],
          "knownEffect": null,
          "lastEdit": 1600293135000,
          "lastReview": null,
          "levelOfEvidence": "LEVEL_Px1",
          "fdaLevel": null,
          "solidPropagationLevel": null,
          "liquidPropagationLevel": null,
          "articles":
          [
            {
              "pmid": "21714648",
              "title": "Clinical effect of point mutations in myelodysplastic syndromes.",
              "journal": "The New England journal of medicine",
              "pubDate": "2011 Jun 30",
              "volume": "364",
              "issue": "26",
              "pages": "2496-506",
              "authors": "Bejar R et al",
              "elocationId": "doi: 10.1056/NEJMoa1013343",
              "link": null,
              "reference": "Bejar R et al. The New England journal of medicine. 2011 Jun 30;364(26)2496-506.",
              "abstract": null
            },
            {
              "pmid": "24220272",
              "title": "Landscape of genetic lesions in 944 patients with myelodysplastic syndromes.",
              "journal": "Leukemia",
              "pubDate": "2014 Feb",
              "volume": "28",
              "issue": "2",
              "pages": "241-7",
              "authors": "Haferlach T et al",
              "elocationId": "doi: 10.1038/leu.2013.336",
              "link": null,
              "reference": "Haferlach T et al. Leukemia. 2014 Feb;28(2)241-7.",
              "abstract": null
            },
            {
              "pmid": "25092778",
              "title": "Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-cell transplantation.",
              "journal": "Journal of clinical oncology : official journal of the American Society of Clinical Oncology",
              "pubDate": "2014 Sep 1",
              "volume": "32",
              "issue": "25",
              "pages": "2691-8",
              "authors": "Bejar R et al",
              "elocationId": "doi: 10.1200/JCO.2013.52.3381",
              "link": null,
              "reference": "Bejar R et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014 Sep 1;32(25)2691-8.",
              "abstract": null
            }
          ]
        }
      ]
    },
    {
      "relevantTumorType": false,
      "tumorType":
      {
        "id": 645,
        "subtype": "Plasma Cell Myeloma",
        "code": "PCM",
        "color": "LimeGreen",
        "mainType": "Mature B-Cell Neoplasms",
        "level": 5,
        "tissue": "Lymphoid",
        "tumorForm": "LIQUID"
      },
      "evidences":
      [
        {
          "id": 25678,
          "uuid": "143077a9-08b8-4800-8c52-db80dad34385",
          "evidenceType": "PROGNOSTIC_IMPLICATION",
          "cancerTypes":
          [
            {
              "id": 645,
              "subtype": "Plasma Cell Myeloma",
              "code": "PCM",
              "color": "LimeGreen",
              "mainType": "Mature B-Cell Neoplasms",
              "level": 5,
              "tissue": "Lymphoid",
              "tumorForm": "LIQUID"
            }
          ],
          "excludedCancerTypes":
          [],
          "relevantCancerTypes":
          [
            {
              "id": 645,
              "subtype": "Plasma Cell Myeloma",
              "code": "PCM",
              "color": "LimeGreen",
              "mainType": "Mature B-Cell Neoplasms",
              "level": 5,
              "tissue": "Lymphoid",
              "tumorForm": "LIQUID"
            }
          ],
          "gene":
          {
            "entrezGeneId": 7157,
            "hugoSymbol": "TP53",
            "oncogene": false,
            "grch37Isoform": "ENST00000269305",
            "grch37RefSeq": "NM_000546.5",
            "grch38Isoform": "ENST00000269305",
            "grch38RefSeq": "NM_000546.5",
            "geneAliases":
            [
              "LFS1",
              "p53"
            ],
            "genesets":
            [],
            "tsg": true
          },
          "alterations":
          [
            {
              "gene":
              {
                "entrezGeneId": 7157,
                "hugoSymbol": "TP53",
                "oncogene": false,
                "grch37Isoform": "ENST00000269305",
                "grch37RefSeq": "NM_000546.5",
                "grch38Isoform": "ENST00000269305",
                "grch38RefSeq": "NM_000546.5",
                "geneAliases":
                [
                  "LFS1",
                  "p53"
                ],
                "genesets":
                [],
                "tsg": true
              },
              "consequence":
              {
                "term": "NA",
                "isGenerallyTruncating": false,
                "description": "NA"
              },
              "alteration": "Deletion",
              "name": "Deletion",
              "refResidues": null,
              "proteinStart": -1,
              "proteinEnd": 100000,
              "variantResidues": null,
              "referenceGenomes":
              [
                "GRCh38",
                "GRCh37"
              ]
            }
          ],
          "description": "This assertion is supported by (PMID: 9680348, 18337559, 17209057 Abstract: Hofste op Bruinink, D. et al. Abstract# Blood 128:3271, 2017. http://www.bloodjournal.org/content/128/22/3271?sso-checked=true; http://www.bloodjournal.org/content/122/21/1846).",
          "additionalInfo": null,
          "treatments":
          [],
          "knownEffect": null,
          "lastEdit": 1600293135000,
          "lastReview": null,
          "levelOfEvidence": "LEVEL_Px1",
          "fdaLevel": null,
          "solidPropagationLevel": null,
          "liquidPropagationLevel": null,
          "articles":
          [
            {
              "pmid": "9680348",
              "title": "Presence of a p53 gene deletion in patients with multiple myeloma predicts for short survival after conventional-dose chemotherapy.",
              "journal": "Blood",
              "pubDate": "1998 Aug 1",
              "volume": "92",
              "issue": "3",
              "pages": "802-9",
              "authors": "Drach J et al",
              "elocationId": "",
              "link": null,
              "reference": "Drach J et al. Blood. 1998 Aug 1;92(3)802-9.",
              "abstract": null
            },
            {
              "pmid": "17209057",
              "title": "Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du My√©lome.",
              "journal": "Blood",
              "pubDate": "2007 Apr 15",
              "volume": "109",
              "issue": "8",
              "pages": "3489-95",
              "authors": "Avet-Loiseau H et al",
              "elocationId": "",
              "link": null,
              "reference": "Avet-Loiseau H et al. Blood. 2007 Apr 15;109(8)3489-95.",
              "abstract": null
            },
            {
              "pmid": null,
              "title": null,
              "journal": null,
              "pubDate": null,
              "volume": null,
              "issue": null,
              "pages": null,
              "authors": null,
              "elocationId": null,
              "link": "http://www.bloodjournal.org/content/128/22/3271?sso-checked=true",
              "reference": "null. null. .",
              "abstract": "Hofste op Bruinink, D. et al. Abstract# Blood 128:3271, 2017"
            },
            {
              "pmid": "18337559",
              "title": "An analysis of the clinical and biologic significance of TP53 loss and the identification of potential novel transcriptional targets of TP53 in multiple myeloma.",
              "journal": "Blood",
              "pubDate": "2008 Nov 15",
              "volume": "112",
              "issue": "10",
              "pages": "4235-46",
              "authors": "Xiong W et al",
              "elocationId": "doi: 10.1182/blood-2007-10-119123",
              "link": null,
              "reference": "Xiong W et al. Blood. 2008 Nov 15;112(10)4235-46.",
              "abstract": null
            }
          ]
        }
      ]
    },
    {
      "relevantTumorType": false,
      "tumorType":
      {
        "id": 533,
        "subtype": "Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma",
        "code": "CLLSLL",
        "color": "LimeGreen",
        "mainType": "Mature B-Cell Neoplasms",
        "level": 5,
        "tissue": "Lymphoid",
        "tumorForm": "LIQUID"
      },
      "evidences":
      [
        {
          "id": 25660,
          "uuid": "8d78d7c1-2bf2-4199-9d9b-8fdb688bb9be",
          "evidenceType": "PROGNOSTIC_IMPLICATION",
          "cancerTypes":
          [
            {
              "id": 533,
              "subtype": "Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma",
              "code": "CLLSLL",
              "color": "LimeGreen",
              "mainType": "Mature B-Cell Neoplasms",
              "level": 5,
              "tissue": "Lymphoid",
              "tumorForm": "LIQUID"
            }
          ],
          "excludedCancerTypes":
          [],
          "relevantCancerTypes":
          [
            {
              "id": 533,
              "subtype": "Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma",
              "code": "CLLSLL",
              "color": "LimeGreen",
              "mainType": "Mature B-Cell Neoplasms",
              "level": 5,
              "tissue": "Lymphoid",
              "tumorForm": "LIQUID"
            }
          ],
          "gene":
          {
            "entrezGeneId": 7157,
            "hugoSymbol": "TP53",
            "oncogene": false,
            "grch37Isoform": "ENST00000269305",
            "grch37RefSeq": "NM_000546.5",
            "grch38Isoform": "ENST00000269305",
            "grch38RefSeq": "NM_000546.5",
            "geneAliases":
            [
              "LFS1",
              "p53"
            ],
            "genesets":
            [],
            "tsg": true
          },
          "alterations":
          [
            {
              "gene":
              {
                "entrezGeneId": 7157,
                "hugoSymbol": "TP53",
                "oncogene": false,
                "grch37Isoform": "ENST00000269305",
                "grch37RefSeq": "NM_000546.5",
                "grch38Isoform": "ENST00000269305",
                "grch38RefSeq": "NM_000546.5",
                "geneAliases":
                [
                  "LFS1",
                  "p53"
                ],
                "genesets":
                [],
                "tsg": true
              },
              "consequence":
              {
                "term": "NA",
                "isGenerallyTruncating": false,
                "description": "NA"
              },
              "alteration": "Oncogenic Mutations",
              "name": "Oncogenic Mutations",
              "refResidues": null,
              "proteinStart": -1,
              "proteinEnd": 100000,
              "variantResidues": null,
              "referenceGenomes":
              [
                "GRCh38",
                "GRCh37"
              ]
            }
          ],
          "description": "This assertion is supported by (PMID: 19188171, 20697090, 24652989, 23243274, 24004666).",
          "additionalInfo": null,
          "treatments":
          [],
          "knownEffect": null,
          "lastEdit": 1600293135000,
          "lastReview": null,
          "levelOfEvidence": "LEVEL_Px1",
          "fdaLevel": null,
          "solidPropagationLevel": null,
          "liquidPropagationLevel": null,
          "articles":
          [
            {
              "pmid": "24652989",
              "title": "Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial.",
              "journal": "Blood",
              "pubDate": "2014 May 22",
              "volume": "123",
              "issue": "21",
              "pages": "3247-54",
              "authors": "Stilgenbauer S et al",
              "elocationId": "doi: 10.1182/blood-2014-01-546150",
              "link": null,
              "reference": "Stilgenbauer S et al. Blood. 2014 May 22;123(21)3247-54.",
              "abstract": null
            },
            {
              "pmid": "23243274",
              "title": "Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia.",
              "journal": "Blood",
              "pubDate": "2013 Feb 21",
              "volume": "121",
              "issue": "8",
              "pages": "1403-12",
              "authors": "Rossi D et al",
              "elocationId": "doi: 10.1182/blood-2012-09-458265",
              "link": null,
              "reference": "Rossi D et al. Blood. 2013 Feb 21;121(8)1403-12.",
              "abstract": null
            },
            {
              "pmid": "24004666",
              "title": "Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome.",
              "journal": "Blood",
              "pubDate": "2013 Oct 10",
              "volume": "122",
              "issue": "15",
              "pages": "2673-82",
              "authors": "Chigrinova E et al",
              "elocationId": "doi: 10.1182/blood-2013-03-489518",
              "link": null,
              "reference": "Chigrinova E et al. Blood. 2013 Oct 10;122(15)2673-82.",
              "abstract": null
            },
            {
              "pmid": "20697090",
              "title": "TP53 mutation and survival in chronic lymphocytic leukemia.",
              "journal": "Journal of clinical oncology : official journal of the American Society of Clinical Oncology",
              "pubDate": "2010 Oct 10",
              "volume": "28",
              "issue": "29",
              "pages": "4473-9",
              "authors": "Zenz T et al",
              "elocationId": "doi: 10.1200/JCO.2009.27.8762",
              "link": null,
              "reference": "Zenz T et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2010 Oct 10;28(29)4473-9.",
              "abstract": null
            },
            {
              "pmid": "19188171",
              "title": "The prognostic value of TP53 mutations in chronic lymphocytic leukemia is independent of Del17p13: implications for overall survival and chemorefractoriness.",
              "journal": "Clinical cancer research : an official journal of the American Association for Cancer Research",
              "pubDate": "2009 Feb 1",
              "volume": "15",
              "issue": "3",
              "pages": "995-1004",
              "authors": "Rossi D et al",
              "elocationId": "doi: 10.1158/1078-0432.CCR-08-1630",
              "link": null,
              "reference": "Rossi D et al. Clinical cancer research : an official journal of the American Association for Cancer Research. 2009 Feb 1;15(3)995-1004.",
              "abstract": null
            }
          ]
        }
      ]
    },
    {
      "relevantTumorType": false,
      "tumorType":
      {
        "id": 695,
        "subtype": "Essential Thrombocythemia",
        "code": "ET",
        "color": "LightSalmon",
        "mainType": "Myeloproliferative Neoplasms",
        "level": 4,
        "tissue": "Myeloid",
        "tumorForm": "LIQUID"
      },
      "evidences":
      [
        {
          "id": 25664,
          "uuid": "b6f54e8b-aa53-4c55-9cd8-5edc0c81fb77",
          "evidenceType": "PROGNOSTIC_IMPLICATION",
          "cancerTypes":
          [
            {
              "id": 695,
              "subtype": "Essential Thrombocythemia",
              "code": "ET",
              "color": "LightSalmon",
              "mainType": "Myeloproliferative Neoplasms",
              "level": 4,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            }
          ],
          "excludedCancerTypes":
          [],
          "relevantCancerTypes":
          [
            {
              "id": 695,
              "subtype": "Essential Thrombocythemia",
              "code": "ET",
              "color": "LightSalmon",
              "mainType": "Myeloproliferative Neoplasms",
              "level": 4,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 330,
              "subtype": "Essential Thrombocythemia Myelofibrosis",
              "code": "ETMF",
              "color": "LightSalmon",
              "mainType": "Myeloproliferative Neoplasms",
              "level": 5,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            }
          ],
          "gene":
          {
            "entrezGeneId": 7157,
            "hugoSymbol": "TP53",
            "oncogene": false,
            "grch37Isoform": "ENST00000269305",
            "grch37RefSeq": "NM_000546.5",
            "grch38Isoform": "ENST00000269305",
            "grch38RefSeq": "NM_000546.5",
            "geneAliases":
            [
              "LFS1",
              "p53"
            ],
            "genesets":
            [],
            "tsg": true
          },
          "alterations":
          [
            {
              "gene":
              {
                "entrezGeneId": 7157,
                "hugoSymbol": "TP53",
                "oncogene": false,
                "grch37Isoform": "ENST00000269305",
                "grch37RefSeq": "NM_000546.5",
                "grch38Isoform": "ENST00000269305",
                "grch38RefSeq": "NM_000546.5",
                "geneAliases":
                [
                  "LFS1",
                  "p53"
                ],
                "genesets":
                [],
                "tsg": true
              },
              "consequence":
              {
                "term": "NA",
                "isGenerallyTruncating": false,
                "description": "NA"
              },
              "alteration": "Oncogenic Mutations",
              "name": "Oncogenic Mutations",
              "refResidues": null,
              "proteinStart": -1,
              "proteinEnd": 100000,
              "variantResidues": null,
              "referenceGenomes":
              [
                "GRCh38",
                "GRCh37"
              ]
            }
          ],
          "description": "This assertion is supported by (PMID: 22887079, 29296692, 24478400).",
          "additionalInfo": null,
          "treatments":
          [],
          "knownEffect": null,
          "lastEdit": 1600293135000,
          "lastReview": null,
          "levelOfEvidence": "LEVEL_Px1",
          "fdaLevel": null,
          "solidPropagationLevel": null,
          "liquidPropagationLevel": null,
          "articles":
          [
            {
              "pmid": "29296692",
              "title": "Targeted deep sequencing in polycythemia vera and essential thrombocythemia.",
              "journal": "Blood advances",
              "pubDate": "2016 Nov 29",
              "volume": "1",
              "issue": "1",
              "pages": "21-30",
              "authors": "Tefferi A et al",
              "elocationId": "doi: 10.1182/bloodadvances.2016000216",
              "link": null,
              "reference": "Tefferi A et al. Blood advances. 2016 Nov 29;1(1)21-30.",
              "abstract": null
            },
            {
              "pmid": "22887079",
              "title": "Clinical significance of genetic aberrations in secondary acute myeloid leukemia.",
              "journal": "American journal of hematology",
              "pubDate": "2012 Nov",
              "volume": "87",
              "issue": "11",
              "pages": "1010-6",
              "authors": "Milosevic JD et al",
              "elocationId": "doi: 10.1002/ajh.23309",
              "link": null,
              "reference": "Milosevic JD et al. American journal of hematology. 2012 Nov;87(11)1010-6.",
              "abstract": null
            },
            {
              "pmid": "24478400",
              "title": "Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms.",
              "journal": "Blood",
              "pubDate": "2014 Apr 3",
              "volume": "123",
              "issue": "14",
              "pages": "2220-8",
              "authors": "Lundberg P et al",
              "elocationId": "doi: 10.1182/blood-2013-11-537167",
              "link": null,
              "reference": "Lundberg P et al. Blood. 2014 Apr 3;123(14)2220-8.",
              "abstract": null
            }
          ]
        }
      ]
    },
    {
      "relevantTumorType": false,
      "tumorType":
      {
        "id": 632,
        "subtype": "Primary Myelofibrosis",
        "code": "PMF",
        "color": "LightSalmon",
        "mainType": "Myeloproliferative Neoplasms",
        "level": 4,
        "tissue": "Myeloid",
        "tumorForm": "LIQUID"
      },
      "evidences":
      [
        {
          "id": 25668,
          "uuid": "7940b806-79c6-4cda-a468-befdd8806bb7",
          "evidenceType": "PROGNOSTIC_IMPLICATION",
          "cancerTypes":
          [
            {
              "id": 632,
              "subtype": "Primary Myelofibrosis",
              "code": "PMF",
              "color": "LightSalmon",
              "mainType": "Myeloproliferative Neoplasms",
              "level": 4,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            }
          ],
          "excludedCancerTypes":
          [],
          "relevantCancerTypes":
          [
            {
              "id": 755,
              "subtype": "Primary Myelofibrosis, Prefibrotic/Early Stage",
              "code": "PMFPES",
              "color": "LightSalmon",
              "mainType": "Myeloproliferative Neoplasms",
              "level": 5,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 632,
              "subtype": "Primary Myelofibrosis",
              "code": "PMF",
              "color": "LightSalmon",
              "mainType": "Myeloproliferative Neoplasms",
              "level": 4,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 493,
              "subtype": "Primary Myelofibrosis,Overt Fibrotic Stage",
              "code": "PMFOFS",
              "color": "LightSalmon",
              "mainType": "Myeloproliferative Neoplasms",
              "level": 5,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            }
          ],
          "gene":
          {
            "entrezGeneId": 7157,
            "hugoSymbol": "TP53",
            "oncogene": false,
            "grch37Isoform": "ENST00000269305",
            "grch37RefSeq": "NM_000546.5",
            "grch38Isoform": "ENST00000269305",
            "grch38RefSeq": "NM_000546.5",
            "geneAliases":
            [
              "LFS1",
              "p53"
            ],
            "genesets":
            [],
            "tsg": true
          },
          "alterations":
          [
            {
              "gene":
              {
                "entrezGeneId": 7157,
                "hugoSymbol": "TP53",
                "oncogene": false,
                "grch37Isoform": "ENST00000269305",
                "grch37RefSeq": "NM_000546.5",
                "grch38Isoform": "ENST00000269305",
                "grch38RefSeq": "NM_000546.5",
                "geneAliases":
                [
                  "LFS1",
                  "p53"
                ],
                "genesets":
                [],
                "tsg": true
              },
              "consequence":
              {
                "term": "NA",
                "isGenerallyTruncating": false,
                "description": "NA"
              },
              "alteration": "Oncogenic Mutations",
              "name": "Oncogenic Mutations",
              "refResidues": null,
              "proteinStart": -1,
              "proteinEnd": 100000,
              "variantResidues": null,
              "referenceGenomes":
              [
                "GRCh38",
                "GRCh37"
              ]
            }
          ],
          "description": "This assertion is supported by (PMID: 22887079, 25516983, 22052707).",
          "additionalInfo": null,
          "treatments":
          [],
          "knownEffect": null,
          "lastEdit": 1600293135000,
          "lastReview": null,
          "levelOfEvidence": "LEVEL_Px1",
          "fdaLevel": null,
          "solidPropagationLevel": null,
          "liquidPropagationLevel": null,
          "articles":
          [
            {
              "pmid": "22887079",
              "title": "Clinical significance of genetic aberrations in secondary acute myeloid leukemia.",
              "journal": "American journal of hematology",
              "pubDate": "2012 Nov",
              "volume": "87",
              "issue": "11",
              "pages": "1010-6",
              "authors": "Milosevic JD et al",
              "elocationId": "doi: 10.1002/ajh.23309",
              "link": null,
              "reference": "Milosevic JD et al. American journal of hematology. 2012 Nov;87(11)1010-6.",
              "abstract": null
            },
            {
              "pmid": "25516983",
              "title": "Genomic and functional analysis of leukemic transformation of myeloproliferative neoplasms.",
              "journal": "Proceedings of the National Academy of Sciences of the United States of America",
              "pubDate": "2014 Dec 16",
              "volume": "111",
              "issue": "50",
              "pages": "E5401-10",
              "authors": "Rampal R et al",
              "elocationId": "doi: 10.1073/pnas.1407792111",
              "link": null,
              "reference": "Rampal R et al. Proceedings of the National Academy of Sciences of the United States of America. 2014 Dec 16;111(50)E5401-10.",
              "abstract": null
            },
            {
              "pmid": "22052707",
              "title": "TP53 mutations and polymorphisms in primary myelofibrosis.",
              "journal": "American journal of hematology",
              "pubDate": "2012 Feb",
              "volume": "87",
              "issue": "2",
              "pages": "204-6",
              "authors": "Raza S et al",
              "elocationId": "doi: 10.1002/ajh.22216",
              "link": null,
              "reference": "Raza S et al. American journal of hematology. 2012 Feb;87(2)204-6.",
              "abstract": null
            }
          ]
        }
      ]
    },
    {
      "relevantTumorType": false,
      "tumorType":
      {
        "id": 185,
        "subtype": "Myeloproliferative Neoplasms",
        "code": "MPN",
        "color": "LightSalmon",
        "mainType": "Myeloproliferative Neoplasms",
        "level": 3,
        "tissue": "Myeloid",
        "tumorForm": "LIQUID"
      },
      "evidences":
      [
        {
          "id": 25666,
          "uuid": "b487b052-7db8-4a2c-8441-ee6b295823c6",
          "evidenceType": "PROGNOSTIC_IMPLICATION",
          "cancerTypes":
          [
            {
              "id": 185,
              "subtype": "Myeloproliferative Neoplasms",
              "code": "MPN",
              "color": "LightSalmon",
              "mainType": "Myeloproliferative Neoplasms",
              "level": 3,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            }
          ],
          "excludedCancerTypes":
          [],
          "relevantCancerTypes":
          [
            {
              "id": 545,
              "subtype": "Chronic Eosinophilic Leukemia, NOS",
              "code": "CELNOS",
              "color": "LightSalmon",
              "mainType": "Myeloproliferative Neoplasms",
              "level": 4,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 806,
              "subtype": "Polycythemia Vera",
              "code": "PV",
              "color": "LightSalmon",
              "mainType": "Myeloproliferative Neoplasms",
              "level": 4,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 330,
              "subtype": "Essential Thrombocythemia Myelofibrosis",
              "code": "ETMF",
              "color": "LightSalmon",
              "mainType": "Myeloproliferative Neoplasms",
              "level": 5,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 43,
              "subtype": "Chronic Neutrophilic Leukemia",
              "code": "CNL",
              "color": "LightSalmon",
              "mainType": "Myeloproliferative Neoplasms",
              "level": 4,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 77,
              "subtype": "Polycythaemia Vera Myelofibrosis",
              "code": "PVMF",
              "color": "LightSalmon",
              "mainType": "Myeloproliferative Neoplasms",
              "level": 5,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 493,
              "subtype": "Primary Myelofibrosis,Overt Fibrotic Stage",
              "code": "PMFOFS",
              "color": "LightSalmon",
              "mainType": "Myeloproliferative Neoplasms",
              "level": 5,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 560,
              "subtype": "Chronic Myelogenous Leukemia",
              "code": "CML",
              "color": "LightSalmon",
              "mainType": "Myeloproliferative Neoplasms",
              "level": 4,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 755,
              "subtype": "Primary Myelofibrosis, Prefibrotic/Early Stage",
              "code": "PMFPES",
              "color": "LightSalmon",
              "mainType": "Myeloproliferative Neoplasms",
              "level": 5,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 597,
              "subtype": "Chronic Myeloid Leukemia, BCR-ABL1+",
              "code": "CMLBCRABL1",
              "color": "LightSalmon",
              "mainType": "Myeloproliferative Neoplasms",
              "level": 5,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 695,
              "subtype": "Essential Thrombocythemia",
              "code": "ET",
              "color": "LightSalmon",
              "mainType": "Myeloproliferative Neoplasms",
              "level": 4,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 632,
              "subtype": "Primary Myelofibrosis",
              "code": "PMF",
              "color": "LightSalmon",
              "mainType": "Myeloproliferative Neoplasms",
              "level": 4,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 185,
              "subtype": "Myeloproliferative Neoplasms",
              "code": "MPN",
              "color": "LightSalmon",
              "mainType": "Myeloproliferative Neoplasms",
              "level": 3,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 831,
              "subtype": "Myeloproliferative Neoplasms, Unclassifiable",
              "code": "MPNU",
              "color": "LightSalmon",
              "mainType": "Myeloproliferative Neoplasms",
              "level": 4,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            }
          ],
          "gene":
          {
            "entrezGeneId": 7157,
            "hugoSymbol": "TP53",
            "oncogene": false,
            "grch37Isoform": "ENST00000269305",
            "grch37RefSeq": "NM_000546.5",
            "grch38Isoform": "ENST00000269305",
            "grch38RefSeq": "NM_000546.5",
            "geneAliases":
            [
              "LFS1",
              "p53"
            ],
            "genesets":
            [],
            "tsg": true
          },
          "alterations":
          [
            {
              "gene":
              {
                "entrezGeneId": 7157,
                "hugoSymbol": "TP53",
                "oncogene": false,
                "grch37Isoform": "ENST00000269305",
                "grch37RefSeq": "NM_000546.5",
                "grch38Isoform": "ENST00000269305",
                "grch38RefSeq": "NM_000546.5",
                "geneAliases":
                [
                  "LFS1",
                  "p53"
                ],
                "genesets":
                [],
                "tsg": true
              },
              "consequence":
              {
                "term": "NA",
                "isGenerallyTruncating": false,
                "description": "NA"
              },
              "alteration": "Oncogenic Mutations",
              "name": "Oncogenic Mutations",
              "refResidues": null,
              "proteinStart": -1,
              "proteinEnd": 100000,
              "variantResidues": null,
              "referenceGenomes":
              [
                "GRCh38",
                "GRCh37"
              ]
            }
          ],
          "description": "This assertion is supported by (PMID: 22887079, 25516983, 22052707).",
          "additionalInfo": null,
          "treatments":
          [],
          "knownEffect": null,
          "lastEdit": 1600293135000,
          "lastReview": null,
          "levelOfEvidence": "LEVEL_Px1",
          "fdaLevel": null,
          "solidPropagationLevel": null,
          "liquidPropagationLevel": null,
          "articles":
          [
            {
              "pmid": "22887079",
              "title": "Clinical significance of genetic aberrations in secondary acute myeloid leukemia.",
              "journal": "American journal of hematology",
              "pubDate": "2012 Nov",
              "volume": "87",
              "issue": "11",
              "pages": "1010-6",
              "authors": "Milosevic JD et al",
              "elocationId": "doi: 10.1002/ajh.23309",
              "link": null,
              "reference": "Milosevic JD et al. American journal of hematology. 2012 Nov;87(11)1010-6.",
              "abstract": null
            },
            {
              "pmid": "25516983",
              "title": "Genomic and functional analysis of leukemic transformation of myeloproliferative neoplasms.",
              "journal": "Proceedings of the National Academy of Sciences of the United States of America",
              "pubDate": "2014 Dec 16",
              "volume": "111",
              "issue": "50",
              "pages": "E5401-10",
              "authors": "Rampal R et al",
              "elocationId": "doi: 10.1073/pnas.1407792111",
              "link": null,
              "reference": "Rampal R et al. Proceedings of the National Academy of Sciences of the United States of America. 2014 Dec 16;111(50)E5401-10.",
              "abstract": null
            },
            {
              "pmid": "22052707",
              "title": "TP53 mutations and polymorphisms in primary myelofibrosis.",
              "journal": "American journal of hematology",
              "pubDate": "2012 Feb",
              "volume": "87",
              "issue": "2",
              "pages": "204-6",
              "authors": "Raza S et al",
              "elocationId": "doi: 10.1002/ajh.22216",
              "link": null,
              "reference": "Raza S et al. American journal of hematology. 2012 Feb;87(2)204-6.",
              "abstract": null
            }
          ]
        }
      ]
    },
    {
      "relevantTumorType": false,
      "tumorType":
      {
        "id": 586,
        "subtype": "Mantle Cell Lymphoma",
        "code": "MCL",
        "color": "LimeGreen",
        "mainType": "Mature B-Cell Neoplasms",
        "level": 5,
        "tissue": "Lymphoid",
        "tumorForm": "LIQUID"
      },
      "evidences":
      [
        {
          "id": 25670,
          "uuid": "e05be7f2-30ba-4b12-84ab-aeba2c0e29ab",
          "evidenceType": "PROGNOSTIC_IMPLICATION",
          "cancerTypes":
          [
            {
              "id": 586,
              "subtype": "Mantle Cell Lymphoma",
              "code": "MCL",
              "color": "LimeGreen",
              "mainType": "Mature B-Cell Neoplasms",
              "level": 5,
              "tissue": "Lymphoid",
              "tumorForm": "LIQUID"
            }
          ],
          "excludedCancerTypes":
          [],
          "relevantCancerTypes":
          [
            {
              "id": 167,
              "subtype": "In Situ Mantle Cell Neoplasia",
              "code": "ISMCL",
              "color": "LimeGreen",
              "mainType": "Mature B-Cell Neoplasms",
              "level": 6,
              "tissue": "Lymphoid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 586,
              "subtype": "Mantle Cell Lymphoma",
              "code": "MCL",
              "color": "LimeGreen",
              "mainType": "Mature B-Cell Neoplasms",
              "level": 5,
              "tissue": "Lymphoid",
              "tumorForm": "LIQUID"
            }
          ],
          "gene":
          {
            "entrezGeneId": 7157,
            "hugoSymbol": "TP53",
            "oncogene": false,
            "grch37Isoform": "ENST00000269305",
            "grch37RefSeq": "NM_000546.5",
            "grch38Isoform": "ENST00000269305",
            "grch38RefSeq": "NM_000546.5",
            "geneAliases":
            [
              "LFS1",
              "p53"
            ],
            "genesets":
            [],
            "tsg": true
          },
          "alterations":
          [
            {
              "gene":
              {
                "entrezGeneId": 7157,
                "hugoSymbol": "TP53",
                "oncogene": false,
                "grch37Isoform": "ENST00000269305",
                "grch37RefSeq": "NM_000546.5",
                "grch38Isoform": "ENST00000269305",
                "grch38RefSeq": "NM_000546.5",
                "geneAliases":
                [
                  "LFS1",
                  "p53"
                ],
                "genesets":
                [],
                "tsg": true
              },
              "consequence":
              {
                "term": "NA",
                "isGenerallyTruncating": false,
                "description": "NA"
              },
              "alteration": "Oncogenic Mutations",
              "name": "Oncogenic Mutations",
              "refResidues": null,
              "proteinStart": -1,
              "proteinEnd": 100000,
              "variantResidues": null,
              "referenceGenomes":
              [
                "GRCh38",
                "GRCh37"
              ]
            }
          ],
          "description": "This assertion is supported by (PMID: 28819011, 26022239, 24684350, 8639789, 7579380).",
          "additionalInfo": null,
          "treatments":
          [],
          "knownEffect": null,
          "lastEdit": 1600293135000,
          "lastReview": null,
          "levelOfEvidence": "LEVEL_Px3",
          "fdaLevel": null,
          "solidPropagationLevel": null,
          "liquidPropagationLevel": null,
          "articles":
          [
            {
              "pmid": "24684350",
              "title": "SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma--a Nordic Lymphoma Group study.",
              "journal": "British journal of haematology",
              "pubDate": "2014 Jul",
              "volume": "166",
              "issue": "1",
              "pages": "98-108",
              "authors": "Nordstr√∂m L et al",
              "elocationId": "doi: 10.1111/bjh.12854",
              "link": null,
              "reference": "Nordstr√∂m L et al. British journal of haematology. 2014 Jul;166(1)98-108.",
              "abstract": null
            },
            {
              "pmid": "8639789",
              "title": "p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis.",
              "journal": "Blood",
              "pubDate": "1996 May 15",
              "volume": "87",
              "issue": "10",
              "pages": "4302-10",
              "authors": "Greiner TC et al",
              "elocationId": "",
              "link": null,
              "reference": "Greiner TC et al. Blood. 1996 May 15;87(10)4302-10.",
              "abstract": null
            },
            {
              "pmid": "7579380",
              "title": "p53 overexpression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32).",
              "journal": "Blood",
              "pubDate": "1995 Oct 15",
              "volume": "86",
              "issue": "8",
              "pages": "2892-9",
              "authors": "Louie DC et al",
              "elocationId": "",
              "link": null,
              "reference": "Louie DC et al. Blood. 1995 Oct 15;86(8)2892-9.",
              "abstract": null
            },
            {
              "pmid": "26022239",
              "title": "High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma.",
              "journal": "Blood",
              "pubDate": "2015 Jul 30",
              "volume": "126",
              "issue": "5",
              "pages": "604-11",
              "authors": "Delfau-Larue MH et al",
              "elocationId": "doi: 10.1182/blood-2015-02-628792",
              "link": null,
              "reference": "Delfau-Larue MH et al. Blood. 2015 Jul 30;126(5)604-11.",
              "abstract": null
            },
            {
              "pmid": "28819011",
              "title": "<i>TP53</i> mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy.",
              "journal": "Blood",
              "pubDate": "2017 Oct 26",
              "volume": "130",
              "issue": "17",
              "pages": "1903-1910",
              "authors": "Eskelund CW et al",
              "elocationId": "doi: 10.1182/blood-2017-04-779736",
              "link": null,
              "reference": "Eskelund CW et al. Blood. 2017 Oct 26;130(17)1903-1910.",
              "abstract": null
            }
          ]
        }
      ]
    },
    {
      "relevantTumorType": false,
      "tumorType":
      {
        "id": 527,
        "subtype": "Acute Myeloid Leukemia",
        "code": "AML",
        "color": "LightSalmon",
        "mainType": "Leukemia",
        "level": 3,
        "tissue": "Myeloid",
        "tumorForm": "LIQUID"
      },
      "evidences":
      [
        {
          "id": 25656,
          "uuid": "e43a1d21-8fe5-454e-8200-34d72533a72e",
          "evidenceType": "PROGNOSTIC_IMPLICATION",
          "cancerTypes":
          [
            {
              "id": 527,
              "subtype": "Acute Myeloid Leukemia",
              "code": "AML",
              "color": "LightSalmon",
              "mainType": "Leukemia",
              "level": 3,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            }
          ],
          "excludedCancerTypes":
          [],
          "relevantCancerTypes":
          [
            {
              "id": 260,
              "subtype": "APL with PML-RARA",
              "code": "APLPMLRARA",
              "color": "LightSalmon",
              "mainType": "Leukemia",
              "level": 5,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 198,
              "subtype": "AML with Recurrent Genetic Abnormalities",
              "code": "AMLRGA",
              "color": "LightSalmon",
              "mainType": "Leukemia",
              "level": 4,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 6,
              "subtype": "Therapy-Related Myelodysplastic Syndrome",
              "code": "TMDS",
              "color": "LightSalmon",
              "mainType": "Leukemia",
              "level": 5,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 390,
              "subtype": "AML (megakaryoblastic) with t(1;22)(p13.3;q13.3);RBM15-MKL1",
              "code": "AMLRBM15MKL1",
              "color": "LightSalmon",
              "mainType": "Leukemia",
              "level": 5,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 844,
              "subtype": "Myeloid Proliferations Related to Down Syndrome",
              "code": "MPRDS",
              "color": "LightSalmon",
              "mainType": "Leukemia",
              "level": 4,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 12,
              "subtype": "AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22);CBFB-MYH11",
              "code": "AMLCBFBMYH11",
              "color": "LightSalmon",
              "mainType": "Leukemia",
              "level": 5,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 590,
              "subtype": "AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM",
              "code": "AMLGATA2MECOM",
              "color": "LightSalmon",
              "mainType": "Leukemia",
              "level": 5,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 527,
              "subtype": "Acute Myeloid Leukemia",
              "code": "AML",
              "color": "LightSalmon",
              "mainType": "Leukemia",
              "level": 3,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 784,
              "subtype": "Myeloid Sarcoma",
              "code": "MS",
              "color": "LightSalmon",
              "mainType": "Leukemia",
              "level": 4,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 16,
              "subtype": "AML without Maturation",
              "code": "AWM",
              "color": "LightSalmon",
              "mainType": "Leukemia",
              "level": 5,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 17,
              "subtype": "AML with Myelodysplasia-Related Changes",
              "code": "AMLMRC",
              "color": "LightSalmon",
              "mainType": "Leukemia",
              "level": 4,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 468,
              "subtype": "Therapy-Related Acute Myeloid Leukemia",
              "code": "TAML",
              "color": "LightSalmon",
              "mainType": "Leukemia",
              "level": 5,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 789,
              "subtype": "AML with Mutated NPM1",
              "code": "AMLNPM1",
              "color": "LightSalmon",
              "mainType": "Leukemia",
              "level": 5,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 149,
              "subtype": "Acute Panmyelosis with Myelofibrosis",
              "code": "APMF",
              "color": "LightSalmon",
              "mainType": "Leukemia",
              "level": 5,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 791,
              "subtype": "AML with t(8;21)(q22;q22.1);RUNX1-RUNX1T1",
              "code": "AMLRUNX1RUNX1T1",
              "color": "LightSalmon",
              "mainType": "Leukemia",
              "level": 5,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 601,
              "subtype": "AML, NOS",
              "code": "AMLNOS",
              "color": "LightSalmon",
              "mainType": "Leukemia",
              "level": 4,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 537,
              "subtype": "Acute Megakaryoblastic Leukemia",
              "code": "AMKL",
              "color": "LightSalmon",
              "mainType": "Leukemia",
              "level": 5,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 27,
              "subtype": "Acute Monoblastic/Monocytic Leukemia",
              "code": "AMOL",
              "color": "LightSalmon",
              "mainType": "Leukemia",
              "level": 5,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 28,
              "subtype": "Pure Erythroid Leukemia",
              "code": "PERL",
              "color": "LightSalmon",
              "mainType": "Leukemia",
              "level": 5,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 29,
              "subtype": "AML with Biallelic Mutations of CEBPA",
              "code": "AMLCEBPA",
              "color": "LightSalmon",
              "mainType": "Leukemia",
              "level": 5,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 671,
              "subtype": "AML with Minimal Differentiation",
              "code": "AMLMD",
              "color": "LightSalmon",
              "mainType": "Leukemia",
              "level": 5,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 864,
              "subtype": "AML with Maturation",
              "code": "AM",
              "color": "LightSalmon",
              "mainType": "Leukemia",
              "level": 5,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 418,
              "subtype": "Therapy-Related Myeloid Neoplasms",
              "code": "TMN",
              "color": "LightSalmon",
              "mainType": "Leukemia",
              "level": 4,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 805,
              "subtype": "AML with Mutated RUNX1",
              "code": "AMLRUNX1",
              "color": "LightSalmon",
              "mainType": "Leukemia",
              "level": 5,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 429,
              "subtype": "AML with t(6;9)(p23;q34.1);DEK-NUP214",
              "code": "AMLDEKNUP214",
              "color": "LightSalmon",
              "mainType": "Leukemia",
              "level": 5,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 246,
              "subtype": "AML with t(9;11)(p21.3;q23.3);MLLT3-KMT2A",
              "code": "AMLMLLT3KMT2A",
              "color": "LightSalmon",
              "mainType": "Leukemia",
              "level": 5,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 822,
              "subtype": "Acute Basophilic Leukemia",
              "code": "ABL",
              "color": "LightSalmon",
              "mainType": "Leukemia",
              "level": 5,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 184,
              "subtype": "AML with BCR-ABL1",
              "code": "AMLBCRABL1",
              "color": "LightSalmon",
              "mainType": "Leukemia",
              "level": 5,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 251,
              "subtype": "Transient Abnormal Myelopoiesis",
              "code": "TAM",
              "color": "LightSalmon",
              "mainType": "Leukemia",
              "level": 5,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 318,
              "subtype": "Acute Myelomonocytic Leukemia",
              "code": "AMML",
              "color": "LightSalmon",
              "mainType": "Leukemia",
              "level": 5,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            },
            {
              "id": 255,
              "subtype": "Myeloid Leukemia Associated with Down Syndrome",
              "code": "MLADS",
              "color": "LightSalmon",
              "mainType": "Leukemia",
              "level": 5,
              "tissue": "Myeloid",
              "tumorForm": "LIQUID"
            }
          ],
          "gene":
          {
            "entrezGeneId": 7157,
            "hugoSymbol": "TP53",
            "oncogene": false,
            "grch37Isoform": "ENST00000269305",
            "grch37RefSeq": "NM_000546.5",
            "grch38Isoform": "ENST00000269305",
            "grch38RefSeq": "NM_000546.5",
            "geneAliases":
            [
              "LFS1",
              "p53"
            ],
            "genesets":
            [],
            "tsg": true
          },
          "alterations":
          [
            {
              "gene":
              {
                "entrezGeneId": 7157,
                "hugoSymbol": "TP53",
                "oncogene": false,
                "grch37Isoform": "ENST00000269305",
                "grch37RefSeq": "NM_000546.5",
                "grch38Isoform": "ENST00000269305",
                "grch38RefSeq": "NM_000546.5",
                "geneAliases":
                [
                  "LFS1",
                  "p53"
                ],
                "genesets":
                [],
                "tsg": true
              },
              "consequence":
              {
                "term": "NA",
                "isGenerallyTruncating": false,
                "description": "NA"
              },
              "alteration": "Oncogenic Mutations",
              "name": "Oncogenic Mutations",
              "refResidues": null,
              "proteinStart": -1,
              "proteinEnd": 100000,
              "variantResidues": null,
              "referenceGenomes":
              [
                "GRCh38",
                "GRCh37"
              ]
            }
          ],
          "description": "This assertion is supported by (PMID: 22186996, 18596741).",
          "additionalInfo": null,
          "treatments":
          [],
          "knownEffect": null,
          "lastEdit": 1600293135000,
          "lastReview": null,
          "levelOfEvidence": "LEVEL_Px1",
          "fdaLevel": null,
          "solidPropagationLevel": null,
          "liquidPropagationLevel": null,
          "articles":
          [
            {
              "pmid": "22186996",
              "title": "TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome.",
              "journal": "Blood",
              "pubDate": "2012 Mar 1",
              "volume": "119",
              "issue": "9",
              "pages": "2114-21",
              "authors": "R√ºcker FG et al",
              "elocationId": "doi: 10.1182/blood-2011-08-375758",
              "link": null,
              "reference": "R√ºcker FG et al. Blood. 2012 Mar 1;119(9)2114-21.",
              "abstract": null
            },
            {
              "pmid": "18596741",
              "title": "TP53 gene mutation is frequent in patients with acute myeloid leukemia and complex karyotype, and is associated with very poor prognosis.",
              "journal": "Leukemia",
              "pubDate": "2009 Jan",
              "volume": "23",
              "issue": "1",
              "pages": "203-6",
              "authors": "Bowen D et al",
              "elocationId": "doi: 10.1038/leu.2008.173",
              "link": null,
              "reference": "Bowen D et al. Leukemia. 2009 Jan;23(1)203-6.",
              "abstract": null
            }
          ]
        }
      ]
    }
  ],
  "vus": false
}
